COSMOFIRSTNSEDecember 31, 2021

COSMO FIRST LIMITED

4,789words
2turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
JAN/10 January 25,2022 The Manager (Listing) Bombay Stock Exchange Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400 001 Scrip Code: 508814 The Manager (Listing) National Stock Exchange of In
62%
cals and a digital first, Petcare business  Speciality Films:  Expanding Speciality portfolio (62% of revenue; 18% annual growth in last 3 years and 20% during FY21). Target 80%+ revenue from Spec
18%
al first, Petcare business  Speciality Films:  Expanding Speciality portfolio (62% of revenue; 18% annual growth in last 3 years and 20% during FY21). Target 80%+ revenue from Speciality by 2023 e
20%
ity Films:  Expanding Speciality portfolio (62% of revenue; 18% annual growth in last 3 years and 20% during FY21). Target 80%+ revenue from Speciality by 2023 end  R&D & Sustainability focus (30+
80%
ciality portfolio (62% of revenue; 18% annual growth in last 3 years and 20% during FY21). Target 80%+ revenue from Speciality by 2023 end  R&D & Sustainability focus (30+ highly qualified polymer/c
22%
pipeline  20% growth targeted from BOPET line (from FY22-23)  FMCG and B2C products launched  22% ROCE and 30% ROE – March 2021  Credit Rating recently enhanced to AA- with stable outlook by CRIS
30%
0% growth targeted from BOPET line (from FY22-23)  FMCG and B2C products launched  22% ROCE and 30% ROE – March 2021  Credit Rating recently enhanced to AA- with stable outlook by CRISIL  Specia
75%
to AA- with stable outlook by CRISIL  Speciality Chemicals:  Masterbatch plant (1st line with 75% captive consumption & 25% outside sale)  Speciality Textile Chemicals – scale up from 21-22 (laun
25%
k by CRISIL  Speciality Chemicals:  Masterbatch plant (1st line with 75% captive consumption & 25% outside sale)  Speciality Textile Chemicals – scale up from 21-22 (launched first FMCG product “F
99.9%
Textile Chemicals – scale up from 21-22 (launched first FMCG product “Fabritizer” which assures a 99.9% protection against viruses and bacteria on clothes including Humasn Coronavirus)  Complimentary
1%
y Films …. Target 80%+ Revenue  Grow specialty portfolio from 62% to 80%+ by 2023 end  Each 1% shift in specialty adds EBITDA ~5 crores  Complimentary growth in Specialized BOPET Line (Shrink
5 crore
 Grow specialty portfolio from 62% to 80%+ by 2023 end  Each 1% shift in specialty adds EBITDA ~5 crores  Complimentary growth in Specialized BOPET Line (Shrink labels, Heat reduction films and other
Risks & concerns — 1 flagged
Neeraj Jain has over two decades of experience in finance, business planning, business strategy, taxation and risk management.
For detail report please refer below link
Advertisement
Speaking time
For detail report please refer below link
2
Opening remarks
For detail report please refer below link
https://www.cosmofilms.com/uploads/investor_relations/Sustainability Report Cosmo Films-17th January.pdf ESG Initiatives (Contd..)
For detail report please refer below link
https://www.cosmofilms.com/uploads/investor_relations/Sustainability Report Cosmo Films-17th January.pdf Board of Directors Mr. Ashok Jaipuria Chairman & Managing Director Mr. A. K. Jain Whole Time Director Mr. H. K. Agrawal Independent Director Our founder Chairman & Managing Director has more than 40 years of experience of the Corporate World. He is a Member of the Executive Committee of the FICCI, president of the Golf Foundation, a member of the Board of Governors of IIT- Patna and among the Board of Directors of DPS, Gurgaon. Mr. Jain has over four decades of experience in Finance and Accounts and General Management functions in industrial enterprises in India. Mr. Jain is a Commerce Graduate from Meerut University and an AICWA from ICWAI and a Certified Information System Auditor from Information System Audit and Control Association, USA. Mr. Agrawal has over four decades of experience in the fields of Strategic Management, Organization Structure, Finance and Training. He is an i
Advertisement
← All transcriptsCOSMOFIRST stock page →